Drug intelligence / Profile preview

perfluorodecalin

Development stage
Phase 1
Lead developer
GC Biopharma
Modality
Nanoparticles → Drug Delivery Systems, Small Molecules
Administration
Intravenous, Topical, Ophthalmic, Intratracheal
01

Overview

Perfluorodecalin is a synthetic fluorocarbon compound in which all hydrogen atoms of decalin are replaced by fluorine. It is chemically and biologically inert and notable for its exceptional ability to dissolve large amounts of gases such as oxygen and carbon dioxide. This property underlies its use in several medical applications including as an ingredient in artificial blood substitutes (e.g., Fluosol), topical oxygen delivery agents for wound healing, organ preservation solutions (notably the "two-layer method" for pancreas transplants), and liquid breathing research. Perfluorodecalin has also been used as a tamponade agent in ophthalmic surgery and as a component of injectable drug delivery systems to improve resuspension of microparticulates. Its mechanism of action is primarily physical—enhancing local or systemic oxygenation by dissolving and delivering high concentrations of oxygen to tissues[1][3][6][8]. It has also demonstrated anti-inflammatory effects in preclinical models[6]. The compound was developed into marketed products such as Fluosol (by Green Cross Corporation) and Perftoran (marketed in Russia). It remains under investigation for wound healing applications[2][3].

Brand names
FluosolPerftoranFiflow
Other names
perfluorodecalin

Beyond the preview

Go deeper on perfluorodecalin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on perfluorodecalin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call